focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Accelerated Bookbuild

6 Mar 2018 08:45

RNS Number : 8091G
Falanx Group Limited
06 March 2018
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN AND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014).

THIS ANNOUNCEMENT IS NOT AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL CONSTITUTE AN OFFERING OF EXISTING ORDINARY SHARES OR NEW ORDINARY SHARES.

CAPITALISED TERMS USED BUT NOT DEFINED IN THIS ANNOUNCEMENT HAVE THE MEANING GIVEN TO THOSE TERMS IN THE COMPANY'S ANNOUNCEMENT TITLED "PROPOSED ACCELERATED BOOKBUILD AND CONDITIONAL ACQUISITION" RELEASED EARLIER TODAY.

Falanx Group Limited

("Falanx" or "the Company")

Result of Accelerated Bookbuild

Falanx (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to announce that further to the announcement made earlier today entitled " Proposed Accelerated Bookbuild and Conditional Acquisition ", the result of the accelerated bookbuild announced earlier today.

Subject to, inter alia, the admission of the Placing Shares, in aggregate 102,222,222 new ordinary shares of nil nominal value in the Company are to be issued, at a placing price of 4.5 pence per New Ordinary Share ("Placing Price"), raising gross proceeds of £4.6million.

The proceeds of the Placing Shares will be used to fund the acquisition consideration for First Base and the remainder for working capital, integration, development expenditure and transaction fees.

The Placing Shares represent 64.9% of Falanx's existing outstanding issued share capital.

Mike Read, Chairman & CEO, commented:

"I am delighted to welcome First Base to the Falanx team. They are a strong business, with great people and customers. We look forward to this acquisition creating shareholder value as we start to deliver the synergies which we expect to achieve. I am delighted that Unicorn Asset Management VCT has subscribed £1.5m and has acted as cornerstone investor and I look forward to working closely with them. Our market is fast paced and remains highly fragmented, moreover, we continue to see plenty of opportunities to consolidate it further with carefully selected acquisitions."

 

Peter Wood, founder of First Base, said:

"We are delighted that our business is joining the Falanx Group. Over the last few months we have got to know Falanx well and there is a good cultural fit between the teams and I am pleased that being part of a larger organisation will provide greater opportunities for all our staff and customers. Whilst I am retiring from the business on a full time basis, I will continue to support the development and integration of the business and the management team through my membership of the Falanx Advisory Board."

Related Party Transactions

The Participating Directors (see below), all of whom are related parties for the purposes of Rule 13 of the AIM Rules for Companies (the "AIM Rules") have agreed to participate in the Placing as follows. The Participating Directors have agreed to subscribe at the Placing Price of 4.5 pence per New Ordinary Share.

 

Director

Number of Existing Ordinary Shares

Number of Placing Shares Subscribed for

Total Ordinary Shares held immediately following the Accelerated Bookbuild

% of Enlarged Share Capital immediately following the Capital Raising

Mike Read

2,577,273

6,666,667

9243940

3.56

Ian Selby

-

666,667

666,667

0.26

Emma Shaw

200,000

666,667

866,667

0.33

 

For the purposes of the AIM Rules, these participations are considered to be related party transactions. John Blamire and Jay Abbott, being the only Directors not participating in the Placing ("Independent Directors"), consider, having consulted with the Company's Nominated Adviser, SPARK Advisory Partners Limited ("SPARK"), that the terms of the Participating Directors' Related Party Transactions are fair and reasonable in so far as the Company's shareholders are concerned. In reaching its opinion, SPARK has taken into account the commercial views of the Directors.

Admission of the new Ordinary Shares to trading on AIM and Total Voting Rights

Application will be made for admission of 102,222,222 new Ordinary Shares to be issued pursuant to the Placing to trading on the AIM Market of the London Stock Exchange, which is expected to take place at 8.00 a.m. on or around 19 March 2018 ("Admission"). The Placing is conditional on Admission becoming effective. The new Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following Admission will consist of 259,678,964 Ordinary Shares of nil ordinary value with voting rights attached (one vote per Ordinary Share). There are no Ordinary Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the DTRs.

 

Enquiries:

 

Falanx Group Limited

Mike Read, Chairman and Chief Executive Officer

John Blamire, COO

Ian Selby, CFO

 

www.falanx.com

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan 

+44 (0) 203 368 3551

 

Turner Pope Investments (TPI) Ltd

+44 (0) 203 621 4120

Bookrunner

Andy Thacker

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 934 6630

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanx.com/ 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNSWRWOAORRR
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.